Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2021

View Archived Issues

RTX-N109D, a rituximab variant with lower sensitivity to CA125 mediated immunosuppression

SRI-42127 attenuates glial activation in a model of LPS-induced neuroinflammation

Gfap-targeted ASO therapy shows efficacy in rat model of Alexander disease

EIDD-2749 shows broad antiviral activity against RSV, SARS-CoV-2 and related RNA viruses

ED to AD: Viagra associated with lower risk of Alzheimer's disease

Jiangsu Protelight Pharmaceutical & Biotechnology patents amino acid derivatives

Shanghai Litedd presents new nuclear receptor RORgammaT antagonists

New ACSS2 inhibitors discovered at Metabomed

Jiangsu Simcere Pharmaceutical R&D discovers SERDs

Incyte describes new mutant GTPase KRAS inhibitors

Phylex develops SARS-CoV-2 vaccine targeting Delta and Omicron variants

Gritstone and CEPI expand agreement for SAM vaccine to target SARS-CoV-2 Omicron variant

Gb Sciences develops cannabinoid-containing complex mixtures to target CRS in COVID-19

Kaleido and Janssen expand Microbiome Metabolic Therapies collaboration

Spago completes regulatory preclinical program with Tumorad

Alpha Cognition reports preclinical data from ALPHA-1062 intranasal TBI program

Bsense reports preclinical data on BSEN-627 in rat pain model

GreenLight and IAVI partner on mRNA vaccine candidate for SARS-CoV-2 Omicron variant